Karolinska Development
 

View full portfolio and sort by:

   

Technology

Karolinska Development has a number of projects with important applications in diagnostics, pharmaceutical formulation, and tailored treatments. Preparation of the active ingredient in a pharmaceutical may have a major impact on how the medicine is absorbed into the body, allowing for lower doses with fewer side effects for patients while increasing the shelf-life of the pharmaceutical and thereby reducing costs. Various technologies may also pave the way for new routes of administration, which may be of great benefit to the patient. The technology portfolio also contains potential improvements to implants for more rapid integration with bone.

 

Concept Development Prototype Development Product Sales

Promimic AB

XSpray Microparticles AB

Inhalation Sciences Sweden AB

NeoDynamics AB (Fourier/AS)

NeoDynamics AB ((Therapy/PRFA) Anti-Meta)

Oss-Q AB

Lipidor AB

Promimic AB

Promimic develops and markets a surface treatment that mimics human tissue for implants in bone tissue for such applications as better anchoring of dental prostheses and polymers for back implants.

www.promimic.com
 

Inhalation Sciences Sweden AB

Inhalation Sciences Sweden has developed a research platform that can provide early stage pharmacokinetic and dynamic data for very early selection of drug candidates.

www.inhalation.se
 

NeoDynamics AB

NeoDynamics works with a new technology for minimally invasive diagnostics and the treatment of early-stage breast cancer.

www.neodynamics.se

XSpray Microparticles AB

XSpray Microparticles helps pharmaceutical companies with the formulation of challenging drug substances based on its proprietary, scalable particle manufacturing technology.

www.xspray.com
 

Oss-Q AB

The company is developing pioneering implants for bone healing with an initial focus on skull surgery.

www.oss-q.com
 

Lipidor AB

Lipidor develops formulation solutions for pharmaceutical substances.

www.lipidor.se